Abstract
The present study describes the chemical synthesis and anticonvulsant activity evaluation of a series of 7- alkoxy-triazolo-[3, 4-b]benzo[d]thiazoles. Most compounds exhibited good anticonvulsant activity in the Maximal electroshock (MES) test. And the structure-activity relationships (SAR) were analyzed. Among the compounds studied, 7- octyloxy-triazolo-[3, 4-b]benzo[d]thiazole (5g) was found to be the most potent compound with a median effective dose (ED50) value of 8.0 mg/kg and a protective index (PI) value of 15.0, possessing better anticonvulsant activity and higher safety than marketed drugs carbamazepine and phenytoin. The mechanism study of compound 5g showed that it displayed broad spectrum activity in several models, and it is likely to have several mechanisms of action (including inhibiting voltage-gated ion channels and GABAergic activity).
Keywords: Synthesis, triazole, benzo[d]thiazoles, anticonvulsant, maximal electroshock, Anticonvulsant Activity, 7-(2-fluorobenzyloxy), 7- alkoxy-triazolo, tetramethysilane, 7-Methoxyl-Triazolo, dichloromethane, 7-Ethoxyl-Triazolo, 7-Pentyloxy-Triazolo, 7-Dodecyloxy-triazolo, 7-(2-Chlorobenzyloxy)-triazolo, 7-(4-Methoxybenzyloxy), Neurotoxicity, Anticonvulsant Effects, Neurotoxicity Screening (NT), Isoniazid-Induced, Bicuculline-Induced, electroshock seizure (MES), 7-octyloxy-triazolo, triazolo-[3, 4-b]benzo[d]thiazole, Quantitative Anticonvulsant, Bicuculline, Carbamazepine, neurotransmission, GABAergic
Medicinal Chemistry
Title: Synthesis and Anticonvulsant Activity of 7-Alkoxy-Triazolo-[3, 4-b] Benzo[d]Thiazoles
Volume: 6 Issue: 5
Author(s): Xian-Qing Deng, Ming-Xia Song, Cheng-Xi Wei, Fu-Nan Li and Zhe-Shan Quan
Affiliation:
Keywords: Synthesis, triazole, benzo[d]thiazoles, anticonvulsant, maximal electroshock, Anticonvulsant Activity, 7-(2-fluorobenzyloxy), 7- alkoxy-triazolo, tetramethysilane, 7-Methoxyl-Triazolo, dichloromethane, 7-Ethoxyl-Triazolo, 7-Pentyloxy-Triazolo, 7-Dodecyloxy-triazolo, 7-(2-Chlorobenzyloxy)-triazolo, 7-(4-Methoxybenzyloxy), Neurotoxicity, Anticonvulsant Effects, Neurotoxicity Screening (NT), Isoniazid-Induced, Bicuculline-Induced, electroshock seizure (MES), 7-octyloxy-triazolo, triazolo-[3, 4-b]benzo[d]thiazole, Quantitative Anticonvulsant, Bicuculline, Carbamazepine, neurotransmission, GABAergic
Abstract: The present study describes the chemical synthesis and anticonvulsant activity evaluation of a series of 7- alkoxy-triazolo-[3, 4-b]benzo[d]thiazoles. Most compounds exhibited good anticonvulsant activity in the Maximal electroshock (MES) test. And the structure-activity relationships (SAR) were analyzed. Among the compounds studied, 7- octyloxy-triazolo-[3, 4-b]benzo[d]thiazole (5g) was found to be the most potent compound with a median effective dose (ED50) value of 8.0 mg/kg and a protective index (PI) value of 15.0, possessing better anticonvulsant activity and higher safety than marketed drugs carbamazepine and phenytoin. The mechanism study of compound 5g showed that it displayed broad spectrum activity in several models, and it is likely to have several mechanisms of action (including inhibiting voltage-gated ion channels and GABAergic activity).
Export Options
About this article
Cite this article as:
Deng Xian-Qing, Song Ming-Xia, Wei Cheng-Xi, Li Fu-Nan and Quan Zhe-Shan, Synthesis and Anticonvulsant Activity of 7-Alkoxy-Triazolo-[3, 4-b] Benzo[d]Thiazoles, Medicinal Chemistry 2010; 6 (5) . https://dx.doi.org/10.2174/157340610793358855
DOI https://dx.doi.org/10.2174/157340610793358855 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Current Options and Perspectives in the Treatment of Diabetic Neuropathy
Current Pharmaceutical Design <i>NeuroArray</i>: A Customized aCGH for the Analysis of Copy Number Variations in Neurological Disorders
Current Genomics Methods and Compositions for Amplification and Detection of microRNAs (miRNAs) and Noncoding RNAs (ncRNAs) Using the Signature Sequence Amplification Method (SSAM)
Recent Advances in DNA & Gene Sequences (Discontinued) Synthesis and Molecular Docking of New Thiophene Derivatives as Lactate Dehydrogenase-A Inhibitors
Mini-Reviews in Medicinal Chemistry Early-Life Lead Exposure: Risks and Neurotoxic Consequences
Current Medicinal Chemistry The Use of Antiepileptic Drugs in Paediatric Neurosurgical Conditions
Current Pharmaceutical Design The Quest for Eldorado: Development of Radioligands for In Vivo Imaging of Nicotinic Acetylcholine Receptors in Human Brain
Current Pharmaceutical Design Recent Progress in the Pharmacology of Imidazo[1,2-a]pyridines
Mini-Reviews in Medicinal Chemistry Lipid-based Nano-phytomedicines for Disease Treatment and Theranostic Applications
Current Nanomedicine Pharmacogenetic Approach to Treating Drug Dependence: Serotonin Transporter Gene (SLC6A4) Promoter Polymorphisms as Treatment Predictors in Jordanian Arabs
Current Pharmacogenomics and Personalized Medicine Tiagabine Incorporated Polymeric Microneedles: Formulation and Characterization Studies
Current Applied Polymer Science The Role of IRE1 Signaling in the Central Nervous System Diseases
Current Neuropharmacology Homocysteine and Cerebral Stroke in Developing Countries
Current Medicinal Chemistry Expanding Spectrum of Sodium Potassium Chloride Co-transporters in the Pathophysiology of Diseases
Current Neuropharmacology Sporadic Porphyria in a Patient with Stage II Melanoma Treated with Interferon α
Current Drug Safety Recent Advances in Synaptosomal Proteomics in Alzheimer’s Disease
Current Protein & Peptide Science Placental Drug Disposition and Its Clinical Implications
Current Drug Metabolism Xenobiotic Acyl Glucuronides and Acyl CoA Thioesters as Protein- Reactive Metabolites With the Potential to Cause Idiosyncratic Drug Reactions
Current Drug Metabolism Editorial
Current Medical Imaging An Overview of HDAC Inhibitors and their Synthetic Routes
Current Topics in Medicinal Chemistry